Literature DB >> 33799968

Predicting Survival in Veterans with Follicular Lymphoma Using Structured Electronic Health Record Information and Machine Learning.

Chunyang Li1,2, Vikas Patil1,2, Kelli M Rasmussen1,2, Christina Yong1,2, Hsu-Chih Chien1,2, Debbie Morreall1,2, Jeffrey Humpherys1,2, Brian C Sauer1,2, Zachary Burningham1,2, Ahmad S Halwani1,2,3.   

Abstract

The most accurate prognostic approach for follicular lymphoma (FL), progression of disease at 24 months (POD24), requires two years' observation after initiating first-line therapy (L1) to predict outcomes. We applied machine learning to structured electronic health record (EHR) data to predict individual survival at L1 initiation. We grouped 523 observations and 1933 variables from a nationwide cohort of FL patients diagnosed 2006-2014 in the Veterans Health Administration into traditionally used prognostic variables ("curated"), commonly measured labs ("labs"), and International Classification of Diseases diagnostic codes ("ICD") sets. We compared performance of random survival forests (RSF) vs. traditional Cox model using four datasets: curated, curated + labs, curated + ICD, and curated + ICD + labs, also using Cox on curated + POD24. We evaluated variable importance and partial dependence plots with area under the receiver operating characteristic curve (AUC). RSF with curated + labs performed best, with mean AUC 0.73 (95% CI: 0.71-0.75). It approximated, but did not surpass, Cox with POD24 (mean AUC 0.74 [95% CI: 0.71-0.77]). RSF using EHR data achieved better performance than traditional prognostic variables, setting the foundation for the incorporation of our algorithm into the EHR. It also provides for possible future scenarios in which clinicians could be provided an EHR-based tool which approximates the predictive ability of the most accurate known indicator, using information available 24 months earlier.

Entities:  

Keywords:  electronic health records; follicular lymphoma; healthcare; machine learning; medical and health data; predictive analytics; prognosis; random survival forest; survival analysis; veterans health administration

Mesh:

Year:  2021        PMID: 33799968      PMCID: PMC7967359          DOI: 10.3390/ijerph18052679

Source DB:  PubMed          Journal:  Int J Environ Res Public Health        ISSN: 1660-4601            Impact factor:   3.390


  33 in total

1.  Evaluating Random Forests for Survival Analysis using Prediction Error Curves.

Authors:  Ulla B Mogensen; Hemant Ishwaran; Thomas A Gerds
Journal:  J Stat Softw       Date:  2012-09       Impact factor: 6.440

Review 2.  Burden of illness of follicular lymphoma and marginal zone lymphoma.

Authors:  Neerav Monga; Loretta Nastoupil; Jamie Garside; Joan Quigley; Moira Hudson; Peter O'Donovan; Lori Parisi; Christoph Tapprich; Catherine Thieblemont
Journal:  Ann Hematol       Date:  2018-10-13       Impact factor: 3.673

3.  High numbers of tumor-infiltrating FOXP3-positive regulatory T cells are associated with improved overall survival in follicular lymphoma.

Authors:  Joaquim Carreras; Armando Lopez-Guillermo; Bridget C Fox; Lluis Colomo; Antonio Martinez; Giovanna Roncador; Emili Montserrat; Elias Campo; Alison H Banham
Journal:  Blood       Date:  2006-07-06       Impact factor: 22.113

4.  Long-term outcome and mortality trends in early-stage, Grade 1-2 follicular lymphoma treated with radiation therapy.

Authors:  Beverly A Guadagnolo; Sigui Li; Donna Neuberg; Andrea Ng; Ling Hua; Barbara Silver; Mary Ann Stevenson; Peter Mauch
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-10-21       Impact factor: 7.038

Review 5.  The importance of identifying and validating prognostic factors in oncology.

Authors:  Susan Halabi; Kouros Owzar
Journal:  Semin Oncol       Date:  2010-04       Impact factor: 4.929

6.  A Selective Review on Random Survival Forests for High Dimensional Data.

Authors:  Hong Wang; Gang Li
Journal:  Quant Biosci       Date:  2017

Review 7.  Unmet needs in the first-line treatment of follicular lymphoma.

Authors:  C Casulo; L Nastoupil; N H Fowler; J W Friedberg; C R Flowers
Journal:  Ann Oncol       Date:  2017-09-01       Impact factor: 32.976

8.  Follicular lymphoma international prognostic index.

Authors:  Philippe Solal-Céligny; Pascal Roy; Philippe Colombat; Josephine White; Jim O Armitage; Reyes Arranz-Saez; Wing Y Au; Monica Bellei; Pauline Brice; Dolores Caballero; Bertrand Coiffier; Eulogio Conde-Garcia; Chantal Doyen; Massimo Federico; Richard I Fisher; Javier F Garcia-Conde; Cesare Guglielmi; Anton Hagenbeek; Corinne Haïoun; Michael LeBlanc; Andrew T Lister; Armando Lopez-Guillermo; Peter McLaughlin; Noël Milpied; Pierre Morel; Nicolas Mounier; Stephen J Proctor; Ama Rohatiner; Paul Smith; Pierre Soubeyran; Hervé Tilly; Umberto Vitolo; Pier-Luigi Zinzani; Emanuele Zucca; Emili Montserrat
Journal:  Blood       Date:  2004-05-04       Impact factor: 22.113

9.  Machine Learning Approaches to Predict 6-Month Mortality Among Patients With Cancer.

Authors:  Ravi B Parikh; Christopher Manz; Corey Chivers; Susan Harkness Regli; Jennifer Braun; Michael E Draugelis; Lynn M Schuchter; Lawrence N Shulman; Amol S Navathe; Mitesh S Patel; Nina R O'Connor
Journal:  JAMA Netw Open       Date:  2019-10-02

10.  Maintenance rituximab in Veterans with follicular lymphoma.

Authors:  Ahmad S Halwani; Kelli M Rasmussen; Vikas Patil; Deborah Morreall; Catherine Li; Christina Yong; Zachary Burningham; Keith Dawson; Anthony Masaquel; Kevin Henderson; Elisha DeLong-Sieg; Brian C Sauer
Journal:  Cancer Med       Date:  2020-08-28       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.